The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 30, 2025 for Sanjiv Goyal & Sanjiv HUF
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoters Sanjiv Goyal and Sanjiv (HUF) have fully released the pledge on their equity shares in Nectar Lifesciences, collectively covering about 44.35% of the company's share capital (Sanjiv Goyal: 55.85 lakh shares at 24.90%; Sanjiv HUF: 43.62 lakh shares at 19.45%). The shares were pledged with a consortium of lenders — Punjab National Bank, SBI, J&K Bank, EXIM Bank, Axis Bank and Shinhan Bank — through SBICAP Trustee Company. The release on October 29, 2025, was triggered because the company itself (Nectar Lifesciences) repaid the underlying loans that were secured by these promoter shares as collateral. After the release, the promoters have zero pledged shares remaining.
This is a constructive signal — the company has cleared a major loan-backed obligation, lifting the encumbrance on a large block of promoter holdings. It typically reduces pledge-related risk overhang on the stock and reassures retail shareholders that the company has improved its debt position, though the underlying value depends on the company's actual financial health post-repayment.